2023
Gender differences in outcomes of early intervention services for first episode psychosis
Hong S, Bennett D, Rosenheck R. Gender differences in outcomes of early intervention services for first episode psychosis. Early Intervention In Psychiatry 2023, 17: 715-723. PMID: 36623822, PMCID: PMC10329725, DOI: 10.1111/eip.13367.Peer-Reviewed Original ResearchMeSH KeywordsAntipsychotic AgentsFemaleHumansMalePsychotic DisordersQuality of LifeSchizophreniaSex FactorsConceptsFirst-episode psychosisEarly intervention servicesClinical trialsEpisode psychosisInitial Schizophrenia Episode-Early Treatment Program (RAISE-ETP) studyEarly interventionIntervention servicesRandomized clinical trialsComorbid substance useUS clinical trialsSignificant gender differencesNegative Syndrome ScaleBaseline gender differencesGender differencesSchizophrenia spectrum disordersAntipsychotic exposureUsual careBaseline characteristicsMood symptomsDepression subscalePsychotic disordersMasked evaluatorsSchizoaffective disorderSyndrome ScaleSecondary analysis
2007
Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
Rosenheck RA, Leslie DL, Sindelar JL, Miller EA, Tariot PN, Dagerman KS, Davis SM, Lebowitz BD, Rabins P, Hsiao JK, Lieberman JA, Schneider LS. Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease. JAMA Psychiatry 2007, 64: 1259-1268. PMID: 17984395, DOI: 10.1001/archpsyc.64.11.1259.Peer-Reviewed Original ResearchConceptsCost-benefit analysisSecond-generation antipsychoticsGreatest net health benefitNet benefit analysisNet health benefitWholesale priceHealth Utilities Index Mark 3Economic perspectiveAlzheimer's diseaseBenefit approachHealth care costsTotal health costsHealth costsQALYsCare costsMeasures of effectivenessPlacebo-controlled trialLower health care costsHealth service useTotal health careMeasures of functionCostTreatment of psychosisQuality of lifeSensitivity analysisEvaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychotics
Rosenheck R. Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychotics. The British Journal Of Psychiatry 2007, 191: 238-245. PMID: 17766765, DOI: 10.1192/bjp.bp.106.035063.Peer-Reviewed Original Research
2001
Stages in the Implementation of Innovative Clinical Programs in Complex Organizations
ROSENHECK R. Stages in the Implementation of Innovative Clinical Programs in Complex Organizations. The Journal Of Nervous And Mental Disease 2001, 189: 812-821. PMID: 11794574, DOI: 10.1097/00005053-200112000-00002.Peer-Reviewed Original ResearchNational Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology
Schneider L, Tariot P, Lyketsos C, Dagerman K, Davis K, Davis S, Hsiao J, Jeste D, Katz I, Olin J, Pollock B, Rabins P, Rosenheck R, Small G, Lebowitz B, Lieberman J. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology. American Journal Of Geriatric Psychiatry 2001, 9: 346-360. PMID: 11739062, DOI: 10.1097/00019442-200111000-00004.Peer-Reviewed Original Research
1999
Enhancing Medication Compliance for People with Serious Mental Illness
Cramer J, Rosenheck R. Enhancing Medication Compliance for People with Serious Mental Illness. The Journal Of Nervous And Mental Disease 1999, 187: 53-55. PMID: 9952254, DOI: 10.1097/00005053-199901000-00009.Peer-Reviewed Original Research
1998
INTERSITE VARIATION IN THE IMPACT OF INTENSIVE PSYCHIATRIC COMMUNITY CARE ON HOSPITAL USE
Rosenheck R, Neale M. INTERSITE VARIATION IN THE IMPACT OF INTENSIVE PSYCHIATRIC COMMUNITY CARE ON HOSPITAL USE. American Journal Of Orthopsychiatry 1998, 68: 191-200. PMID: 9589758, DOI: 10.1037/h0080329.Peer-Reviewed Original Research
1993
Characteristics of Veterans and Nonveterans in Three Samples of Homeless Men
Rosenheck R, Koegel P. Characteristics of Veterans and Nonveterans in Three Samples of Homeless Men. Psychiatric Services 1993, 44: 858-863. PMID: 8225299, DOI: 10.1176/ps.44.9.858.Peer-Reviewed Original ResearchConceptsHomeless veteransGeneral populationHomeless nonveteransCharacteristics of veteransHomeless male veteransHigher educational levelHomeless menClinical characteristicsMale veteransMental illnessCurrent social functioningSecondary analysisSubstance abuseSociodemographic differencesPhysical healthAmerican menSocial functioningVeteransNational dataHomeless AmericansNonveteransEducational levelMenHomeless population
1990
Mentally ill chemical abusers discharged from VA inpatient treatment: 1976–1988
Rosenheck R, Massari L, Astrachan B, Suchinsky R. Mentally ill chemical abusers discharged from VA inpatient treatment: 1976–1988. Psychiatric Quarterly 1990, 61: 237-249. PMID: 2103008, DOI: 10.1007/bf01064864.Peer-Reviewed Original ResearchConceptsIll chemical abusersChemical abusersVeterans Affairs Medical CenterSubstance abuse diagnosisMental illness diagnosisSubstance abuse treatmentDischarge abstractsInpatient treatmentMedical CenterAbuse diagnosisPsychiatric patientsPsychiatric diagnosisIllness diagnosisAbuse treatmentPatientsDiagnosisYear periodSame fiscal yearAbusersTreatmentYearsAdmissionHospital